Colgate Palmolive vs PROCTER & GAMBLE (CL vs PG)
Side by side from their SEC filings: revenue, margins, growth, returns and valuation, plus short interest, insider activity and institutional ownership.
PROCTER & GAMBLE is the larger company by revenue ($87.0B vs $20.4B) and market value ($370.1B vs $75.0B). Colgate Palmolive has grown revenue faster over the last 4 fiscal years (+17.0% cumulative vs +8.5%). PROCTER & GAMBLE runs the higher operating margin (22.7% vs 16.2%). PROCTER & GAMBLE trades at the lower trailing P/E (24.1x vs 37.1x).
About Colgate Palmolive
Colgate-Palmolive Company produces and sells oral, personal, and home care products as well as pet nutrition products. Its oral care segment includes toothpaste, toothbrushes, and mouthwashes sold under brands like Colgate and elmex, while personal care products include soaps, deodorants, and skin health items under brands such as Palmolive and Softsoap. The pet nutrition segment offers specialty pet foods for dogs and cats marketed under brands like Hill’s Science Diet and Prescription Diet.
About PROCTER & GAMBLE
Procter & Gamble Company is a multinational consumer goods company that creates, manufactures, markets, and distributes a wide range of daily-use branded products. Its products are sold in about 180 countries through various channels including retail stores, e-commerce, and direct-to-consumer platforms. The company serves customers such as mass merchandisers, grocery stores, drug stores, and specialty retailers, with a focus on product performance, packaging, brand communication, retail execution, and value.
Head to head (CL FY2025 vs PG FY2026)
| Metric | CLFY2025 | PGFY2026 |
|---|---|---|
| Revenue | $20.38B | $87.03B |
| Revenue growth (YoY) | 1.4% | 3.3% |
| Gross margin | 60.1% | 50.2% |
| Operating margin | 16.2% | 22.7% |
| Net margin | 10.5% | 18.4% |
| Net income | $2.13B | $16.05B |
| Diluted EPS | $2.63 | $6.62 |
| FCF margin | 17.8% | 17.4% |
| ROE | 584.1% | 29.5% |
| Long-term debt / equity | 18.82× | 0.42× |
| Market cap | $75.02B | $370.12B |
| P/E | 37.1× | 24.1× |
Fundamentals are from each company’s SEC filings (CL FY2025, PG FY2026). ROE is net income over fiscal-year-end equity; long-term debt / equity counts non-current term debt only. P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
Five-year trend (as reported)
| CL by fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.42B | $17.97B | $19.46B | $20.10B | $20.38B |
| Net income | $2.17B | $1.78B | $2.30B | $2.89B | $2.13B |
| Operating margin | 19.1% | 16.1% | 20.5% | 21.2% | 16.2% |
| PG by fiscal year | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $80.19B | $82.01B | $84.04B | $84.28B | $87.03B |
| Net income | $14.74B | $14.65B | $14.88B | $15.97B | $16.05B |
| Operating margin | 22.2% | 22.1% | 22.1% | 24.3% | 22.7% |
Colgate Palmolive and PROCTER & GAMBLE use different fiscal calendars (CL's FY2025 ended 2025-12-31, PG's FY2026 ended 2026-06-30), so their fiscal years are shown separately rather than forced into one timeline.
Peer standing
Where each company ranks among the 131 Consumer Staples companies, on the same scale. Each figure is ranked only against peers that report it. Percentiles describe position in the distribution, not a rating.
| Metric | CL | PG |
|---|---|---|
| Gross margin | 60.1%85th percentile of 113 | 50.2%78th percentile of 113 |
| Operating margin | 16.2%88th percentile of 117 | 22.7%94th percentile of 117 |
| Net margin | 10.5%81st percentile of 121 | 18.4%92nd percentile of 121 |
| FCF margin | 17.8%93rd percentile of 114 | 17.4%91st percentile of 114 |
| Revenue growth (YoY) | +1.4%39th percentile of 127 | +3.3%49th percentile of 127 |
| ROE | 584.1%Highest of 114 | 29.5%93rd percentile of 114 |
| P/E | 37.1×83rd percentile of 77 | 24.1×59th percentile of 77 |
| Long-term debt / equity | 18.82×99th percentile of 82 | 0.42×47th percentile of 82 |
| Short interest (days to cover) | 4.01d55th percentile of 129 | 3.24d41st percentile of 129 |
Short interest
| FINRA settlement data | CL | PG |
|---|---|---|
| Shares sold short | 24.0M | 24.4M |
| Change vs prior settlement | +30.7% | +0.9% |
| Days to cover | 4.01 | 3.24 |
| As of settlement | 2026-09-30 | 2026-09-30 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data; republishing or redistributing it is not permitted. Not presented as a percentage of float. No FINRA endorsement of this product is implied.
Insider activity (last 90 days)
| Form 4 activity (codes P/S) | CL | PG |
|---|---|---|
| Buys | 0 | 0 |
| Sells | 4 ($31.0M) | 17 ($7.5M) |
Non-derivative purchases (code P) and sales (code S) reported on SEC Form 4, which may be open-market or private (grants, exercises and tax withholding excluded). For context, about 15% of covered companies saw any reported insider purchase (code P) in a 90-day window.
Held by the same investors
10 tracked 13F managers hold both Colgate Palmolive and PROCTER & GAMBLE as of their latest quarterly filings: AQR Capital Management, Bridgewater Associates, Citadel Advisors, D. E. Shaw, Dodge & Cox, Gotham Asset Management, Millennium Management, Point72 Asset Management, Two Sigma Investments, Yacktman Asset Management. See which superinvestors hold your own portfolio with the smart money checker.
Go deeper
Track CL and PG
Get an alert when either company files something material, see which superinvestors own them, and ask their filings a question with cited answers.
Start monitoring freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filings before relying on them. Comparisons are descriptive (higher or lower on a reported figure), not a rating or a recommendation. Informational only. Not investment advice.